Floatz logo

CYTARABINE

Acute Myeloid Leukemia With CEBPA Somatic Mutations

The First Affiliated Hospital of Soochow UniversitySmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Acute Myeloid Leukemia With CEBPA Somatic Mutations cohort.

Asset / SponsorPhaseRating
Venetoclax
The First Affiliated Hospital of Soochow University
Phase 1/2CCC

Same molecule, other indications

CYTARABINE is also rated in:

acute promyelocytic leukemiaActive
A
Indicative · Phase 4
82 / 100
View asset →
adult acute lymphoblastic leukemiaActive
BBB
Indicative · Phase 4
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative · Phase 3
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →